Slide 1: Second Quarter Earnings
Second Quarter Earnings Celanese 2Q 2005 Earnings NYSE: CE Conference Call/Webcast Tues., August 9, 2005 10 a.m CT David Weidman, CEO C.J. Nelson, CFO 1 Forward-Looking Statements This presentation may contain “forward-looking statements,” which include information concerning the Company’s plans, ob
Slide 2: Use of Non-GAAP Financial Information
measures to U.S. GAAP figures, see the accompanying schedules to this release. 3 Use of Non-GAAP Financial Information Adjusted EBITDA, a measure used by management to measure performance, is defined as earnings (loss) from continuing operations, plus interest expense net of interest income, income
Slide 3: Strong Underlying Business Results
Strong Underlying Business Results (in $millions) 2nd Qtr 2005 Sales $1,517 up 23% Operating Profit $152 up 508% Adjusted Diluted EPS $0.53 Dividends from Equity & Cost Investments $17 Adjusted EBITDA $283 up 51% Expansion of operating profit and strengthened cash position Higher pricing on strong d
Slide 4: Chemical Products, Ticona, Acetate/Performance Products Summaries
Adjusted Diluted EPS $0.53 n.m. Adjusted EBITDA 283 188 8 Chemicals Products (in $millions) 2nd Qtr 05 Sales $1,085 up 34% Segment Earnings(1) $149 up 338% Second Quarter: Significant price increases on robust demand, high industry capacity utilization Pricing more than offset higher raw material co
Slide 5: Significant Contribution from Equity and Cost Investments
(in $millions) 2nd Qtr 05 Sales $183 up 6% Segment $12 down 14% Earnings(1) Acetate Strong results on higher volumes, pricing and productivity improvements China venture expansions moving forward Restructuring of operations on schedule, temporary higher manufacturing costs due to production/inventor
Slide 6: Capitalization and Combined Business Outlook
13 Capitalization (in $millions) December 31, March 31, June 30, 2004 2005 2005 Cash 838 1,738 959 Senior Credit Term Loan 624 1,750 1,725 Delayed Draw Term Loan - - - Floating Rate Term Loan 350 - - Total Senior Debt 974 1,750 1,725 Senior Sub Notes ($) 1,231 800 800 Senior Sub Notes (€ - 6/30/05 t
Slide 7: Depreciation, Special Charges and Interest Expense Guidance
($ millions) Common stock = 158.5 million outstanding Depreciation = $250-$270 Potentially dilutive securities as of 6/30: Special charges = $100-$110 Interest expense = $290-$300 12 million shares – converted preferred Cash interest = $235-$245 12 million shares - stock options @ Excluding deferred